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Abstract
Adenoviruses are DNA viruses that naturally infect many vertebrates, including humans and monkeys, and cause a wide
range of clinical illnesses in humans. Infection from individual strains has conventionally been thought to be species-
specific. Here we applied the Virochip, a pan-viral microarray, to identify a novel adenovirus (TMAdV, titi monkey
adenovirus) as the cause of a deadly outbreak in a closed colony of New World monkeys (titi monkeys; Callicebus cupreus)a t
the California National Primate Research Center (CNPRC). Among 65 titi monkeys housed in a building, 23 (34%) developed
upper respiratory symptoms that progressed to fulminant pneumonia and hepatitis, and 19 of 23 monkeys, or 83% of those
infected, died or were humanely euthanized. Whole-genome sequencing of TMAdV revealed that this adenovirus is a new
species and highly divergent, sharing ,57% pairwise nucleotide identity with other adenoviruses. Cultivation of TMAdV was
successful in a human A549 lung adenocarcinoma cell line, but not in primary or established monkey kidney cells. At the
onset of the outbreak, the researcher in closest contact with the monkeys developed an acute respiratory illness, with
symptoms persisting for 4 weeks, and had a convalescent serum sample seropositive for TMAdV. A clinically ill family
member, despite having no contact with the CNPRC, also tested positive, and screening of a set of 81 random adult blood
donors from the Western United States detected TMAdV-specific neutralizing antibodies in 2 individuals (2/81, or 2.5%).
These findings raise the possibility of zoonotic infection by TMAdV and human-to-human transmission of the virus in the
population. Given the unusually high case fatality rate from the outbreak (83%), it is unlikely that titi monkeys are the native
host species for TMAdV, and the natural reservoir of the virus is still unknown. The discovery of TMAdV, a novel adenovirus
with the capacity to infect both monkeys and humans, suggests that adenoviruses should be monitored closely as potential
causes of cross-species outbreaks.
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Introduction
Adenoviruses, first isolated in the 1950s from explanted adenoid
tissue, are double-stranded nonenveloped DNA viruses that
naturally infect many vertebrates, including humans and nonhu-
man primates. The human adenoviruses in the Mastadenovirus
genus, comprised of all mammalian adenoviruses, are classified
into 7 species A-G, and at least 51 different serotypes (and 5
proposed types, HAdV-52 to HAdV-56) have been described to
date [1,2]. Adenoviruses are the cause of an estimated 5–10% of
febrile illnesses in children worldwide [3]. Some serotypes, such as
human adenovirus type 14 (HAdV-14), have been associated with
severe and potentially fatal outbreaks of pneumonia in residential
facilities and military bases [4]. Adenoviruses have also been
associated with other clinical syndromes including conjunctivitis,
hepatitis, and diarrhea [5]. In nonhuman primates, most
epidemiologic studies of adenoviruses have focused on their
identification in fecal samples from asymptomatic animals [6,7,8].
Overt respiratory disease associated with simian adenoviruses has
also been observed [9]. Although adenoviruses are significant
pathogens, genetically modified strains are being actively explored
as potential vectors for vaccines and gene therapy [10].
Infection by adenoviruses has generally been thought to be
species-specific. Human adenoviruses do not usually replicate in
monkey cells in the absence of helper viruses [11], and do not
productively infect rodents (and vice versa) [12]. Studies of sera
from animal handlers and zoo workers exposed to chimpanzees in
captivity fail to detect antibodies to chimpanzee adenoviruses
PLoS Pathogens | www.plospathogens.org 1 July 2011 | Volume 7 | Issue 7 | e1002155[13,14]. However, recent serological surveys have found antibod-
ies to New World and Old World monkey adenoviruses in donor
human sera from regions where the monkeys are endemic [14,15].
In addition, phylogenetic analyses of adenoviruses from greater
apes reveal that they fall precisely into ‘‘human’’ adenoviral species
B, C, and E [7]. The high degree of sequence relatedness within
members of each species suggests that at least some adenoviral
strains may be capable of infecting both nonhuman primates and
humans.
Beginning in May of 2009, a deadly outbreak of fulminant
pneumonia and hepatitis occurred in a closed colony of New
World titi monkeys of the Callicebus genus at the California
National Primate Research Center (CNPRC). Routine microbi-
ological testing for an infectious etiology was negative. We
previously developed the Virochip (University of California, San
Francisco) as a broad-spectrum surveillance assay for identifying
viral causes of unknown acute and chronic illnesses
[16,17,18,19,20,21,22]. The Virochip, a pan-viral microarray
containing ,19,000 probes derived from all viral species in
GenBank (n,2500) [21,23], has been previously successful in
detection of novel outbreak viruses such as the SARS coronavirus
[22,24] and the 2009 pandemic H1N1 influenza virus [23]. Here
we apply the Virochip to identify a novel and highly divergent
adenovirus as the cause of the titi monkey outbreak. In addition,
we present clinical and serological evidence that this virus may
have infected a researcher at the CNPRC and a family member,
thus demonstrating for the first time the potential for cross-species
infection by adenoviruses.
Results
An outbreak of fulminant pneumonia in a titi monkey
colony
In early 2009, the CNPRC housed 65 titi monkeys in one
quadrant of an animal building. The index case, a healthy adult
titi monkey, presented on May 14, 2009 with cough, lethargy, and
decreased appetite (Fig. 1A, T1). Despite aggressive treatment with
intravenous fluids and antibiotics, the animal developed severe
respiratory distress and was humanely euthanized 5 days later. A
second case presented 4 weeks later near the entrance to the
building (Fig. 1A, T54). In the interim period, 3 healthy titi
monkeys had been relocated from a separate building (Fig. 1A, T2,
T3, and T19), with 2 of the 3 monkeys placed into the cage
formerly occupied by the index case, reflecting a total at-risk
population of 68. Over the ensuing 2 months, 21 additional
monkeys, including one of the relocated monkeys, presented with
clinical signs similar to those shown by the index case (attack rate
=23/68, or 34%) (Figs. 1A and 1B). Clinical signs in affected
animals included cough, lethargy, poor appetite, tachypnea, and
abdominal breathing. These symptoms progressed to overt
respiratory distress and death or humane euthanasia within an
average of 8 days. Chest radiographs typically revealed diffuse
interstitial pulmonary changes and bronchoalveolar consolidation
indicative of pneumonia, with right middle lobe predominance
(Fig. 1C). Animals displaying clinical signs were quarantined and
aggressively treated by veterinarians with supplemental oxygen,
anti-inflammatory medications, bronchodilators (nebulized albu-
terol), broad-spectrum antibiotics, and antivirals (oseltamivir and/
or ribavirin). In total, 19 animals died or were euthanized due to
the illness during the outbreak (case fatality rate =19/23, or 83%).
Only 4 monkeys survived, even though the majority of sick
animals (17/23, or 74%) consisted of apparently healthy adults
and juveniles. Interestingly, none of the 133 rhesus macaques
(Macaca mulatta) housed in the same building became sick during
the outbreak, and neither did any of the Old World monkeys from
surrounding outdoor colonies of rhesus and cynomolgus macaques
(Macaca fascicularis).
Gross necropsy findings were similar in all titi monkeys and
were characterized primarily by diffuse, consolidated pneumonias,
with occasional evidence of fibrinous pleuritis, pericardial/pleural
edema, and hemorrhage (Fig. 1D-1). Some livers, spleens, and
lymph nodes were found to be abnormally enlarged. Hepatic
necrosis and hemorrhage, along with ascites, were occasionally
appreciated. On histologic examination, the normal cellular
architecture of the lung and trachea was destroyed, and prominent
intranuclear inclusion bodies were observed in the liver, lung, and
trachea (Figs. 1D-2 and 1D-3).
A routine microbiological workup for infectious causes of the
outbreak, including bacterial, mycoplasma, and fungal cultures,
was negative. Respiratory viral testing failed to detect evidence of
respiratory syncytial virus, adenovirus, influenza virus A and B,
human metapneumovirus, and parainfluenza virus types 1, 2, and
3.
Virochip identification, PCR screening and electron
microscopic (EM) confirmation of TMAdV
Given the clinical presentation of a severe acute viral respiratory
illness and the appearance of intranuclear inclusion bodies on
histological examination, we strongly suspected that a virus that
had eluded detection by conventional assays was the cause of the
titi monkey outbreak. Nasal, lung, and liver swab samples collected
during necropsy were analyzed using the Virochip [21,23].
Microarrays were analyzed using ranked Z-scores to assess the
highest-intensity viral probes [18]. From a lung swab sample from
an affected monkey, 4 of the top 80 probes on the Virochip
corresponded to adenoviruses. Other viruses or viral families with
$4 probes among the top 80, including chimpanzee herpesvirus
(Herpesviridae), bovine viral diarrhea virus (Flaviviridae), and
endogenous retroviruses (Retroviridae), were regarded as less likely
to cause fulminant pneumonia and hepatitis, so were not pursued
any further. The 4 adenovirus probes mapped to 2 different gene
regions corresponding to the DNA polymerase and penton base
Author Summary
Infection from adenoviruses, viruses that cause a variety of
illnesses in humans, monkeys, and other animals, has
conventionally been thought to be species-specific. We
used the Virochip, a microarray designed to detect all
viruses, to identify a new species of adenovirus (TMAdV, or
titi monkey adenovirus) that caused a deadly outbreak in a
colony of New World titi monkeys at the California
National Primate Research Center (CNPRC), and also
infected a human researcher. One-third of the monkeys
developed pneumonia and liver inflammation, and 19 of
23 monkeys died or were humanely euthanized. The
unusually high death rate (83%) makes titi monkeys
unlikely to be natural hosts for TMAdV, and the genomic
sequence of TMAdV revealed that it is very different from
any other known adenovirus. The researcher developed an
acute respiratory illness at the onset of the outbreak, and
was found to be infected by TMAdV by subsequent
antibody testing. A clinically ill family member with no
prior contact with the CNPRC also tested positive. Further
investigation is needed to identify whether TMAdV
originated from humans, monkeys, or another animal.
The discovery of TMAdV suggests that adenoviruses
should be monitored closely as potential causes of cross-
species outbreaks.
Cross-Species Transmission of a Novel Adenovirus
PLoS Pathogens | www.plospathogens.org 2 July 2011 | Volume 7 | Issue 7 | e1002155Figure 1. Clinical and epidemiologic features of the titi monkey outbreak. (A) Map of the titi monkey cages situated in one quadrant of a
building, showing the locations of asymptomatic, at-risk monkeys (brown or green), affected surviving monkeys (black), and monkeys who died from
their illness (skeleton). 3 monkeys were moved into the building (arrows pointing down and to the left) and 4 monkeys out of the building (arrows
pointing up and to the right) during the 3
rd week of the outbreak. The upper left photograph shows an image of an adult male titi monkey and his
infant. The upper right inset shows the location of the titi monkey cages relative to other rhesus monkey cages in the building. Asymptomatic
monkeys with positive serum antibody titers to TMAdV 4 months after the outbreak are shown in green. (B) Epidemic curve of the outbreak, with the
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PLoS Pathogens | www.plospathogens.org 3 July 2011 | Volume 7 | Issue 7 | e1002155(Fig. 2A). Interestingly, the 4 viral probes were derived from 2
different Adenoviridae genera (SAdV-23, simian adenovirus 23,
PAdV-A, porcine adenovirus A, and HAdV-5, human adenovirus
5, in the Mastadenovirus genus; FAdV-D, fowl adenovirus D, in the
Aviadenovirus genus), suggesting the presence of a divergent
adenovirus that was not a member of any previously known
species.
To confirm the Virochip finding of an adenovirus, we used
consensus primers to amplify a 301 bp fragment from the hexon
gene by PCR [25]. The fragment shared ,86% nucleotide
identity with its closest phylogenetic relatives in GenBank, SAdV-
18, an Old World vervet monkey adenovirus, and the human
species D adenoviruses. The newly identified adenovirus was
designated TMAdV, or titi monkey adenovirus. Specific PCR for
TMAdV was then used to screen body fluids and tissues from
affected monkeys (Table 1). PCR results were positive from post-
necropsy liver and lung tissues as well as from sera, conjunctival
swabs, oral swabs, and nasal swabs collected at time of quarantine
in 8 different affected monkeys, but were negative from a throat
swab from an asymptomatic animal whose other 5 cage mates had
become sick. In addition, nasal swabs were negative in 3
asymptomatic, minimal-risk titi monkeys housed in a separate
building. To confirm the presence of virus in diseased tissues, we
examined lung tissue from affected monkeys by transmission
electron microscopy, revealing abundant icosahedral particles
characteristic of adenovirus filling the alveoli (Fig. 1D-4).
Next, to assess persistent subclinical infection from TMAdV, we
analyzed serum samples from at-risk asymptomatic or affected
surviving monkeys 2 months after the outbreak (n=41). All post-
outbreak serum samples were negative for TMAdV by PCR
(Table 1). To assess potential TMAdV shedding, stool samples
collected from all cages housing titi monkeys 2 months post-
outbreak were analyzed by PCR (n=27), and were found to be
negative. In addition, we checked for TMAdV in rectal swab
samples from rhesus macaques housed in the same building as the
titi monkeys (n=26) and in pooled droppings from wild rodents
(n=2) living near the titi monkey cages. All macaque and rodent
fecal samples were negative for TMAdV by PCR.
We also sought to determine whether PCR assays commonly
used to detect human adenoviruses in clinical or public health
settings could detect TMAdV. Adenovirus PCR was performed on
a TMAdV-positive clinical sample, a TMAdV culture, and a
human adenovirus B culture (as a positive control) using an
additional 5 pairs of primers, according to previously published
protocols [26,27,28] Three of the 5 primer pairs, designed to
detect human respiratory adenoviruses B, C, and E, failed to
amplify TMAdV [27]. The remaining 2 pairs of primers, both
derived from highly conserved sequences in the hexon gene
[26,28], were able to detect TMAdV in culture as well as directly
from clinical material.
Whole-genome sequencing, features, and phylogenetic
analysis of TMAdV
To facilitate whole-genome sequencing of TMAdV, deep
sequencing of a lung swab from one affected titi monkey and
lung tissue from another affected monkey was performed. Out of
,11.9 million high-quality reads, 2,782 reads and 3,767 reads
aligned to the SAdV-18 genome by BLASTN (Fig. 2B, blue) and
TBLASTX (Fig. 2B, transparent blue), respectively, with reads
mapping to sites across the genome. De novo assembly of the
complete TMAdV genome from reads that aligned to SAdV-18
was not possible due to insufficient sequence coverage (,46%).
The poor apparent coverage was the result of high sequence
divergence of the TMAdV genome from SAdV-18, which
hindered the identification of most of the 16,524 actual deep
sequencing reads derived from TMAdV (Fig. 2B, red). Thus, after
partial assembly of TMAdV using overlapping reads aligning to
the SAdV-18 genome, remaining gaps were closed by specific
PCR. The complete genome of TMAdV was found to be 36,842
base pairs in length, with a base composition of 20.8% A, 29.8%
C, 29.8% G, and 19.6% T, and a GC content of 59.6%,
comparable to that of adenoviral species Groups C, D, and E in
the Mastadenovirus genus. The deduced genomic structure of
TMAdV was also similar to that of other mastadenoviruses and
consists of 34 open reading frames (Fig. 2C).
Whole-genome phylogenetic analysis placed TMAdV in an
independent species group separate from the known human
adenoviral species A–G (Fig. 3). Among all 95 fully-sequenced
adenovirus genomes in GenBank, the closest simian adenoviral
relatives to TMAdV were SAdV-3, SAdV-18, and SAdV-21, with
pairwise nucleotide identities ranging from 54.0% to 56.3%
(Fig. 4). The closest human adenoviral relatives were the species D
adenoviruses, which share 54.3% to 55.1% identity to TMAdV,
with human adenoviruses of other species slightly less similar
(51.1%–54.6%). The placement of TMAdV into a separate group
by phylogenetic analysis was also observed when looking
individually at the hexon, polymerase, penton base, and fiber
genes (Fig. S1). Scanning nucleotide pairwise identity plots
revealed that, among the major adenovirus genes, the DNA
polymerase and hexon are more conserved, whereas the E1A and
fiber are more divergent (Fig. 4). The significant overall sequence
divergence of TMAdV from known human and simian adenovi-
ruses is highlighted by the finding that PAdV-A (porcine
adenovirus A), a non- primate mammalian adenovirus, shared
only a slightly less similar whole-genome pairwise identity to
TMAdV of 47.0% (Fig. 4). In fact, in the DNA polymerase gene,
TMAdV shared a pairwise identity with PAdV-A of 67.2%,
comparable to its pairwise identities with the other human
adenoviruses, 59%–71.7% (Figs. 4 and S1). Although TMAdV
was found to be highly divergent from other adenoviruses,
different isolates of TMAdV from 3 affected titi monkeys were
remarkably conserved, sharing 100% identity across the full-length
hexon gene (data not shown).
The high level of sequence divergence in TMAdV held true at
the amino acid level as well, with amino acid identities relative to
other mastadenoviruses ranging from 20.8% to 27.5% for the
fiber, the most divergent protein, to 68.7%–78.2% for the hexon
(Table 2). Although bearing low sequence similarity to other
adenoviruses, the penton base of TMAdV contained an RGD
motif that presumably binds av integrins. By both nucleotide and
amino acid comparisons, the closest phylogenetic relative to
number of cases in blue and cumulative attack rate in red. (C) Anteroposterior chest radiograph of an affected titi monkey, showing bilateral basilar
infiltrates and a prominent right middle lobe consolidation. (D) 1 – gross photograph of lungs at necropsy; the lungs failed to fully collapse upon
opening the chest, and a single ,1.5 cm focus of dark red discoloration (hemorrhage) can be seen in the left caudal lobe. 2 – photomicrograph of
H&E stained lung tissue showing a severe diffuse necrotizing bronchopneumonia characterized by the presence of hemorrhage and intranuclear
inclusions (arrows). 3 – photomicrograph of H&E stained liver tissue showing a multifocal necrotizing hepatitis with numerous intranuclear inclusions
(arrows). 4 – transmission electron micrograph of an affected lung alveolus (scale bar =1 mm) filled with adenovirus-like particles (inset, scale bar
=0.1 mm).
doi:10.1371/journal.ppat.1002155.g001
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PLoS Pathogens | www.plospathogens.org 4 July 2011 | Volume 7 | Issue 7 | e1002155Figure 2. Discovery and whole-genome characterization of the novel adenovirus TMAdV. (A) The locations of the 4 Virochip probes
derived from adenovirus sequences and used to detect TMAdV are mapped onto the ,37 kB genome. The 4 Virochip probe sequences are also
aligned with the corresponding sequence in the TMAdV genome, with mismatches highlighted in pink. (B) Coverage map of deep sequencing reads
corresponding to TMAdV using BLASTN (blue) and TBLASTX (transparent blue) alignments to SAdV-18. The actual coverage achieved by deep
sequencing as determined by alignments to the fully sequenced genome of TMAdV is much higher (red). (C) Genome organization of TMAdV.
Predicted protein coding regions are shown as boxes. Boxes above the central black line represent open reading frames (ORFs) that are encoded on
the forward strand, while boxes underneath the black line represent reverse-strand encoded ORFs. Early region ORFs are shaded in gray. The x-axis
refers to the nucleotide position along the ,37k genome of TMAdV. Abbreviations: FAdV, fowl adenovirus; SAdV, simian adenovirus; PAdV, porcine
adenovirus; HAdV, human adenovirus, TMAdV, titi monkey adenovirus.
doi:10.1371/journal.ppat.1002155.g002
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Bootscanning analysis revealed no evidence for recombination of
TMAdV with other adenoviruses at either the whole-genome or
individual gene level (Fig. S2).
The main neutralization determinant for adenoviruses, the
epsilon determinant (e), is formed by loops 1 and 2 in the hexon
protein [29]. The epsilon determinant of TMAdV was
significantly divergent from that of other mastadenoviruses,
with amino acid identities in loop 1 varying from 30.6% to
44.8% and in loop 2 varying from 54.4% to 67.0% (Table 2).
This observation suggested that cross-neutralization of TMAdV
with sera reactive against other human/simian adenoviruses is
unlikely.
Cultivation of TMAdV in human and monkey cells
We next attempted to culture TMAdV in an A549 (human lung
adenocarcinoma) cell line, a BSC-1 (African green monkey kidney
epithelial) cell line, and PMK (primary rhesus monkey kidney) cells
(Fig. 5). Direct inoculation of cell cultures with a lung swab sample
from an affected titi monkey produced a weak initial cytopathic
Table 1. PCR screening for TMAdV.
Sample Sample Type PCR Result Date Presenting with Clinical Signs Date of Necropsy
Affected, at-risk titi monkeys (died)
T1 serum
1 2 5/14/2009 5/19/2009
T26 serum
" + 7/23/2009 7/30/2009
T28 conjunctival swab








" + 7/26/2009 7/31/2009
T30 serum
" 2 7/25/2009 7/30/3009
T33 lung swab








" 2 7/15/2009 7/22/2009
T63 serum
" 2 6/20/2009 8/1/2009
T67 nasal swab
# 2 7/7/2009 8/13/2009
nasal swab
" +
Affected, at-risk titi monkeys (survived)
T31 serum* 2 7/10/2009 N/A
T32 serum* 2 7/12/2009 N/A
T34 serum* 2 6/23/2009 N/A
T62 serum* 2 7/8/2009 N/A
Asymptomatic at-risk and minimal-risk titi monkeys
T27 throat swab (n=1)
" 2 N/A N/A
at-risk titi stool from cages (n=14)* 2 N/A N/A
at-risk titi serum (n=29)* 2 N/A N/A
minimal-risk titi oral swab (n=3)
" 2 N/A N/A
minimal-risk titi stool from cages (n=5)* 2 N/A N/A
minimal-risk titi serum (n=8)* 2 N/A N/A
minimal-risk titi stool from cages (n=8)* 2 N/A N/A
minimal-risk titi serum (n=8)* 2 N/A N/A
Other
rhesus rectal swabs (n=26)* 2 N/A N/A
human serum (n=15)
‘ 2 N/A N/A
rodent droppings (n=2)* 2 N/A N/A
For titi monkey cage designations (TXX), please refer to Fig. 1.
1initial case.
#collected prior to outbreak.
"collected during outbreak.
*collected 2 months after outbreak.
‘collected 4 months after outbreak.
doi:10.1371/journal.ppat.1002155.t001
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However, despite multiple serial passages, we were unable to
propagate the infected cell culture supernatant in either BSC-1 or
PMK cells. In contrast, propagation in human A549 cells resulted
in viral adaptation by passage 6 and generation of a fully adapted
strain of TMAdV by passage 10 that was able to productively
infect all 3 cell lines. Thus, culturing and propagation of TMAdV
were successful in a human A549 cell line, but not in established or
primary monkey kidney cell lines.
An influenza-like illness in a researcher and family
members during the titi monkey outbreak
In hindsight, only one individual at the CNPRC reported
becoming ill during the titi monkey outbreak, the researcher in
closest, daily contact with the animals. Symptoms began near the
onset of the outbreak, although whether they began prior to or
after identification of the index case is unclear. The researcher,
with a past medical history of multiple sclerosis, initially developed
symptoms of a viral upper respiratory infection (URI), including
Figure 3. Whole-genome phylogenetic analysis of TMAdV. The whole-genome nucleotide phylogenetic tree is reconstructed from a multiple
sequence alignment of all 95 unique, fully-sequenced adenovirus genomes in GenBank and TMAdV. Both rectangular cladogram and radial tree
layouts are displayed. The branch corresponding to TMAdV is highlighted in boldface red. Abbreviations: HAdV, human adenovirus; SAdV, simian
adenovirus; MAdV, mouse adenovirus, FrAdV, frog adenovirus; TAdV, turkey adenovirus; SnAdV, snake adenovirus; DAdV, duck adenovirus; OAdV,
ovine adenovirus; BAdV, bovine adenovirus; PAdV, porcine adenovirus; TSAdV, tree shrew adenovirus; CAdV, canine adenovirus.
doi:10.1371/journal.ppat.1002155.g003
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PLoS Pathogens | www.plospathogens.org 7 July 2011 | Volume 7 | Issue 7 | e1002155Figure 4. Scanning pairwise alignment of representative adenoviruses with TMAdV. The scanning nucleotide pairwise identities of TMAdV
relative to representative human (yellow) or simian (brown) adenoviruses in species A–G, porcine adenovirus (red), and fowl adenovirus (green) are
shown. The window size is 400 bp with a step size of 40 bp. The x-axis refers to the nucleotide position along the ,37 k genome of TMAdV.
Abbreviations: HAdV, human adenovirus; SAdV, simian adenovirus; PAdV, porcine adenovirus; FAdV, fowl adenovirus.
doi:10.1371/journal.ppat.1002155.g004
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and ‘‘burning sensation in the lungs’’ that was exacerbated by a
deep breath or coughing. The researcher endorsed a history of
recurrent upper respiratory infections, and did not regard the
illness as related to the titi monkey outbreak. Although symptoms
persisted for 4 weeks, at no time did the researcher seek medical
care, and no antibiotics were taken during the illness.
We carried out contact tracing to identify family members and
other individuals in close contact with the researcher. Interestingly,
two family members in the household also developed flu-like
symptoms about 1–2 weeks after the researcher initially became
sick. Their symptoms – fever, cough and muscle aches – appeared
milder than those of the researcher and completely resolved within
2 weeks. Neither individual sought medical care for these
symptoms, and notably, neither had ever visited the CNPRC.
Seroprevalence of TMAdV in monkeys and humans
To explore a potential link between the outbreak and associated
illness in humans, we blindly tested available sera from titi
monkeys (n=59), rhesus macaques housed in the same building
(n=36), CNPRC personnel and close contacts (n=20), and
random human blood donors (n=81) for evidence of recent or
prior infection by TMAdV by virus neutralization (Fig. 6).
Nineteen serum samples from 15 at-risk affected (symptomatic)
titi monkeys were tested. Among 3 affected titi monkeys surviving
the outbreak, 2 monkeys mounted a vigorous neutralizing Ab
response to TMAdV, with negative pre-outbreak Ab titers (,1:8)
but antibody titers 2 months after the outbreak of .1:512, while 1
monkey exhibited a positive but much weaker response. Affected
titi monkeys who died during the outbreak exhibited a wide range
of neutralizing Ab titers, from ,1:8 to .1:512 (those without Ab
likely died before mounting a response).
To investigate the possibility of subclinical infection by
TMAdV, we also examined serum samples from asymptomatic
titi monkeys (n=40) and nearby rhesus macaques (n=36),
collected 2 months after the outbreak. Fourteen of 40 asymptom-
atic titi monkeys tested (35%) had antibody to TMAdV, indicating
that the incidence of subclinical infection was significant (Fig. 1A;
Fig 6). In fact, one of the 14 asymptomatic titi monkeys with
positive Ab titers was located in the minimal-risk building. In
contrast, only 1 of 36 rhesus macaque samples was positive, with
an Ab titer of 1:16. The 1 antibody-positive rhesus serum sample
was negative by specific PCR for TMAdV (data not shown), as was
stool from the cage in which the rhesus monkey was housed
(Table 1).
Approximately 4 months after the outbreak, serum samples
were collected from CNPRC personnel in direct contact with the
titi monkeys. Serum samples were also collected from the two
family members of the clinically ill CNPRC researcher 1 year after
the outbreak. Only two samples were found positive for
neutralizing Abs to TMAdV: (1) Ab titers for the clinically ill
researcher were 1:32, and (2) Ab titers for one of the family
members of the clinically ill researcher were 1:8.
Among 81 random blood donors from the Western United
States, 2 individuals (2/81, 2.5%) had positive Ab titers of 1:16 and
1:8. Pooled rabbit sera containing antibodies to human adenovirus
serotypes 1 through 35, representing species A–E, were unable to
neutralize TMAdV (data not shown). Thus, the results of our
serological survey appear unlikely to be due to nonspecific cross-
reactivity from prior exposure to known human adenoviruses.
Discussion
In this study, we employed a pan-viral microarray assay, the
Virochip, to identify a novel adenovirus associated with a
fulminant pneumonia outbreak in a colony of New World titi
monkeys. Despite the absence of an animal model, which
precludes a strict fulfillment of Koch’s postulates, there are several
lines of evidence implicating this novel adenovirus, TMAdV, as
Table 2. Amino acid identity of TMAdV relative to other adenoviruses.









SAdV-3 (rhesus monkey) 26.6% 29.9% 37.9% 61.8% 68.2%* 70.6%* 78.2%* 44.8%* 67.0%*
SAdV-18 (vervet monkey) 26.0% 30.7% 39.1% 63.2% 66.5% 68.3% 76.7% 39.1% 63.9%
HAdV-12 (species A) 26.4% 31.0% 38.2% 60.4% 64.3% 67.6% 76.2% 40.1% 64.9%
HAdV-3 (species B) 22.3% 31.4% 36.5% 61.7% 65.8% 68.8% 73.7% 38.3% 63.9%
SAdV-21 (species B) 22.2% 30.6% 36.0% 62.1% 66.1% 68.8% 72.2% 34.1% 61.2%
HAdV-2 (species C) 25.0% 32.6%* 39.5% 62.5% 67.0% 68.0% 71.4% 39.1% 61.4%
SAdV-42 (species C) 26.4% 30.5% 38.8% 62.5% 66.5% 68.1% 72.4% 37.4% 63.3%
HAdV-9 (species D) 21.9% 28.4% 38.3% 63.4% 66.1% 68.3% 74.0% 33.3% 60.0%
HAdV-36 (species D) 20.8% 30.0% 38.1% 63.3% 65.9% 68.3% 73.6% 33.1% 61.9%
HAdV-4 (species E) 26.3% 32.6%* 37.1% 62.8% 67.9% 69.8% 72.7% 30.6% 63.3%
SAdV-22 (species E) 27.5%* 31.2% 36.8% 62.9% 67.6% 70.4% 74.2% 38.6% 63.9%
HAdV-40 (species F) 26.9% 31.0% 40.1%* 62.1% 64.1% 65.9% 77.1% 42.6% 66.3%
SAdV-7 (species G) 25.5% 32.6%* 34.9% 63.3% 67.0% 68.0% 76.4% 43.8% 59.6%
HAdV-52 (species G) 24.1% 30.3% 35.6% 63.8%* 67.8% 67.9% 77.0% 46.2%* 62.6%
PAdV-A (porcine) 26.4% 23.6% 37.4% 55.4% 61.7% 57.7% 68.7% 36.4% 54.4%
FAdV-A (fowl) 1.6% N/A 25.8% 36.5% 41.6% 31.7% 47.9% 22.3% 39.0%
The amino acid sequences of selected TMAdV proteins and the epsilon determinant of the hexon (e: L1, loop 1, and e: L2, loop 2) are compared to the corresponding
proteins from representative human, simian, porcine, and fowl adenoviruses.
*For each protein, the entry corresponding to the adenoviral species with the highest percentage identity relative to TMAdV.
doi:10.1371/journal.ppat.1002155.t002
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pathogens, including other viruses by Virochip, was negative, and
affected monkeys did not respond to empiric therapy with
antibiotics or antivirals (ribavirin and oseltamivir in anecdotal
use are not effective against adenoviral infections) [30]. Second,
the clinical presentation of pneumonia and hepatitis is consistent
with the known spectrum of disease associated with adenoviral
infections. Third, TMAdV sequence was recovered by PCR in
various body fluids and tissues from affected monkeys, including
blood, respiratory secretions, and lung/liver tissue (Table 1).
Fourth, the finding of intranuclear inclusions in diseased tissues, as
well as direct visualization of adenoviral-like particles (TMAdV) in
lung alveoli by electron microscopy (Figs. 1D-2 to 1D-4), support a
primary role for TMAdV in the pathogenesis of tissue injury in
affected monkeys. Finally, there was a significant neutralizing Ab
response in surviving animals, with 2 monkeys having titers
undetectable prior to the outbreak but rising to .1:512 at
convalescence (Fig. 6).
Although TMAdV retains the core genomic features common
to all adenoviruses (Fig. 2C), phylogenetic analysis clearly places
TMAdV within a separate branch, with no closely related
neighbors (Figs. 3 and S1). A phylogenetic distance of .10%
combined with the lack of cross-neutralization defines TMAdV as
a new species [31]. Since emerging adenovirus strains such as
HAdV-14 and HAdV-D22/H8 (otherwise known as HAdV-D53)
are known to arise from recombination events among related
ancestral strains [32,33], we performed bootscanning analysis to
look for such events in TMAdV. The bootscanning analysis,
however, failed to show evidence of recombination, likely because
closely related and/or ancestral strains to TMAdV have not yet
been identified.
Entry of adenoviruses into cells involves an initial attachment of
the fiber knob to the cell receptor, followed by internalization via a
secondary interaction of the penton base with av integrins [34,35].
The presence of an RGD motif in the TMAdV penton base
implies that the virus uses av integrins for internalization [35].
However, the high sequence divergence in the fiber protein (Table
2), as well as the absence of fiber motifs conserved among
adenoviruses that bind CAR [36,37] (coxsackievirus-adenovirus
receptor) or CD46 [38,39,40] (data not shown), suggest that
neither of these two human adenoviral receptors may be the
attachment receptor for TMAdV. Further studies will be necessary
to identify the preferred cellular attachment and internalization
receptors for TMAdV.
Figure 5. Growth and propagation of TMAdV in cell culture. The flow chart displays 10 passages (P1–P10) of TMAdV cultured in human lung
adenocarcinoma (A549, orange), primary rhesus macaque kidney (PMK, brown), or established African green monkey kidney (BSC-1, green) cells.
doi:10.1371/journal.ppat.1002155.g005
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to propagate TMAdV in both established (BSC-1) and primary
(PMK) monkey kidney cells (Fig. 4). The virus, however, grew
efficiently in a human A549 lung adenocarcinoma cell line. One
explanation for this finding is that TMAdV may be unable to
productively infect cells derived from Old World monkeys (e.g.
rhesus and African green monkeys). An alternative possibility is
that successful propagation of TMAdV may depend on infection
of a specific host cell type, such as A549 lung, and not BSC-1 or
PMK kidney cells. Nevertheless, after 10 passages in human A549
cells, the fully adapted strain of TMAdV exhibits an extended host
range with the ability to productively infect both monkey and
human cells. This observation implies that TMAdV possesses an
inherent capacity to cross the species barrier and infect both
humans and nonhuman primates. Efforts to identify host range
and cell tropism of TMAdV, as well as the specific sequence
changes responsible for adaptation to growth in cell culture, are
currently underway.
The virulence of TMAdV in healthy and apparently immuno-
competent titi monkeys (83% case fatality rate) is highly unusual for
infections by adenovirus. In humans, deaths due to adenovirus
infections or outbreaks are generally low (up to 18% for pneumonia
associated with HAdV-14 [4]). Furthermore, severe infections from
human adenoviruses are more commonly associated with older age,
immunosuppression, and chronic underlying conditions such as
kidney failure [4,41]. Young, healthy individuals are in general
much less likely to succumb to adenoviral-related illness. The
severity of TMAdV-related illness in affected titi monkeys suggests
that this species of monkey may not be the natural host for the virus.
The failure to detect fecal shedding of TMAdV in convalescent or
asymptomatic animals also suggests that the virus does not normally
infect titi monkeys (Table 1).
Although the exact origin of TMAdV remains unclear, we can
speculate on several possibilities. One possibility is that a cross-
species ‘‘jump’’ from captive macaques to a susceptible colony of
titi monkeys precipitated the outbreak. As there have been no new
introductions of monkeys into the closed colony for the past 2
years, this conjecture relies on asymptomatic infection and
transmission of TMAdV in the captive rhesus/cynomolgus
macaque population at the CNPRC. CNPRC personnel who
visited macaque areas would occasionally enter titi rooms with no
change in personal protective equipment, thus providing a
potential route of transmission for the virus. In addition, specific
antibodies were detected in 1 of 36 (2.8%) asymptomatic rhesus
macaques housed in the same building (Fig. 6), indicating that
TMAdV has the capacity to infect this species of Old World
monkey. Notably, the closest identified phylogenetic relative to
TMAdV among the complete genomic sequences available in
GenBank is a rhesus monkey adenovirus, SAdV-3 (Fig. 4; Table
2). Furthermore, serological evidence for cross-species adenoviral
transmission events between different nonhuman primate species
has been previously reported in the literature [42].
Figure 6. Seroprevalence of TMAdV in humans and monkeys. Sera from titi monkeys (circles), rhesus macaques (squares), and humans
(triangles) were tested for antibodies to TMAdV by virus neutralization. Arrows designate pre-outbreak and post-outbreak serum samples from the
same individual monkey. Pre-outbreak serum samples were previously banked in 2007. Sera from CNPRC personnel and close contacts (orange
triangles) were collected 4 months post-outbreak, except for the two family members of the clinically ill researcher, whose sera were collected 1 year
post-outbreak. *, clinically ill researcher; **, family member of the researcher, who was also sick. Abbreviations: CNPRC, California National Primate
Research Center; NEG, negative.
doi:10.1371/journal.ppat.1002155.g006
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found near titi monkey cages (Table 2), it is still possible that the
virus arose from an unknown animal reservoir. In this regard, the
high sequence divergence of TMAdV relative to the known
human/simian adenoviruses (Fig. 3), and comparable sequence
similarity in the polymerase gene to a porcine adenovirus (Figs. 3
and S1) are striking. The four-week interval between the index
case and the second case appears overly long given a typical
incubation period for adenovirus infections of no more than 1
week [43]. This may be explained by our finding of a high rate of
subclinical infection by TMAdV in asymptomatic titi monkeys
(35%), but may also be due to separate introductions of TMAdV
into the colony from an as-yet unidentified reservoir.
Our study data also support the potential for cross-species
transmission of TMAdV between monkeys and humans. The
researcher’s fever, cough, and pleuritic symptoms (‘‘burning
sensation in the lungs’’) are consistent with the development of a
prolonged viral respiratory illness. Interestingly, pleurisy has been
specifically reported in association with certain human adenovirus
infections [44]. The clinical presentation, time of illness concurrent
with the onset of the outbreak, and presence of neutralizing Abs in
convalescent serum all strongly point to primary infection of the
researcher by TMAdV. The detection of weakly neutralizing Abs
(1:8) in a serum sample from a sick family member of the
researcher also suggests that TMAdV may be capable of human-
to-human transmission. The decreased levels of neutralizing Abs
to TMAdV in the researcher (1:32) and a family member (1:8)
relative to those in infected titi monkeys (up to .1:512) are
consistent with a recent study showing much higher levels of
neutralizing antibodies in chimpanzees than in humans with
adenovirus infections, possibly due to more robust adenovirus-
specific T-cell responses in humans than in monkeys [45].
Severallines of evidence support the contention that the direction
of TMAdV transmission was zoonotic (monkeys to humans) rather
than anthroponotic (humans to monkeys). First, the closest known
relative to TMAdV in GenBank is SAdV-3, an Old World monkey
adenovirus (Fig. 3; Table 2). Second, our results show that PCR
assays for human adenoviruses in common use are capable of
detecting TMAdV. Although sequencing of PCR amplicons for
human adenoviruses is not performed routinely in diagnostic
virology, TMAdV would presumablyhavebeen detected previously
in large-scale studies of hexon sequencing of Ad field isolates if it
were circulating in the community [46,47]. Finally, the available
sequence data in GenBank is heavily biased towards human
adenoviruses, and much less is known about the potential diversity
of the simian adenoviruses. We also cannot formally exclude the
possibility that the outbreak arose from anthroponotic transmission.
In our study, 2 of 81, or 2.5% of random adult blood donors
exhibited borderline titers of neutralizing antibody to TMAdV,
indicating either a low prevalence of TMAdV in the human
population or cross-reactivity to a related virus (although no
evidence of cross-reactivity was found with HAdV serotypes 1
through 35). Future large-scale studies of TMAdV seroepidemiol-
ogy will be needed to better understand transmission of TMAdV
between monkeys and humans. Nevertheless, our discovery of
TMAdV, a novel adenovirus with the capacity to cross species
barriers, highlights the need to monitor adenoviruses closely for
outbreak or even pandemic potential.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
use and care of all animals followed policies and guidelines
established by the University of California, Davis Institutional
Animal Care and Use Committee (IACUC) and CNPRC (Animal
Welfare Assurance #A3433-01). The protocol for the mainte-
nance and breeding of the titi monkey colony was approved by the
University of California, Davis IACUC (Protocol #15730). No
specific animal research protocol was drafted for this study, as only
excess clinical samples were analyzed for diagnostic purposes.
Animals in extreme respiratory distress were humanely euthanized
by veterinarians. Extensive veterinary care was provided to all
animals affected by the outbreak in order to minimize pain and
distress.
Serum samples from staff at the CNPRC, close contacts, and
random adult blood donors were collected under protocols
approved by institutional review boards of the University of
California, Davis (Protocol #200917650-1) and University of
California, San Francisco (Protocol #H49187-35245-01). Specif-
ically, written informed consent was obtained from staff at the
CNPRC and close contacts for analysis of their samples. Any
potentially identifying information has been provided with the
explicit permission of the individuals involved.
Sera from random blood donors were obtained from the Blood
Systems Research Institute (San Francisco, CA); sera were derived
from affiliated donor banks in California (Blood Centers of the
Pacific, San Francisco, CA), Nevada (United Blood Service, Reno,
NV), and Wyoming (United Blood Services, Cheyenne, Wyoming)
and de-identified prior to analysis.
The California National Primate Research Center (CNPRC)
The California National Primate Research Center (CNPRC),
which houses over 5,000 nonhuman primates, is a part of the
National Primate Research Centers Program and is accredited by
the Association for the Assessment and Accreditation of Labora-
tory Animal Care, International (AAALAC). At the beginning of
2009, the CNPRC maintained a colony of 74 titi monkeys
(Callicebus cupreus) and a colony of over 4,500 rhesus macaques
(Macaca mulatta). No new animals have been introduced into either
colony for over 2 years. All titi monkeys are maintained in small
social groups, while rhesus macaques are maintained in small or
large social groups. All animal facilities are maintained in
compliance with United States Department of Agriculture
specifications.
Eighty-eight percent of the titi monkey population (n=65) were
housed in 1 quadrant of an indoor animal building, and all titi
monkeys demonstrating clinical signs originated from this building
(i.e. ‘‘at-risk’’ room) (Fig. 1A). Rhesus macaques (n=133) were
housed in the other 3 quadrants of this same building, and
surrounding the building were outdoor housing units with rhesus
macaques and cynomolgus macaques (Macaca fasicularis). Three
additional titi monkeys were moved into the at-risk room less than
2 weeks after presentation of the index case, reflecting a total at-
risk population of 68 animals. The remaining 6 titi monkeys were
housed in an indoor animal building greater than 500 yards from
the at-risk population (i.e. ‘‘minimal-risk’’ room).
Outbreak investigation and microbiological testing
The outbreak lasted approximately 3 months from May to
August of 2009. Affected titi monkeys died from 3–24 days after
appearance of clinical signs, with an average time to death or
humane euthanasia of 8 days. Clinical and epidemiological data,
including daily census reports, were tracked and recorded by
veterinary and management staff. All personnel entering the titi
monkey rooms (both at-risk rooms and minimal-risk rooms)
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enclosures prior to entry. CNPRC personal protective equipment
(PPE) policy requires a change of PPE between entrance/exit of
animal rooms housing different species. Staff compliance of this
policy may have been compromised. Measures have since been
taken by CNPRC management to ensure compliance with existing
policies.
Bacterial, mycoplasma, and fungal cultures were performed at
the CNPRC. Clinical samples were also sent to an outside
laboratory (Focus Diagnostics, Cypress, CA) for respiratory viral
testing by centrifugation-enhanced shell vial culture followed by
direct fluorescent antibody staining for 8 viruses (respiratory
syncytial virus, adenovirus, influenza virus A and B, parainfluenza
virus types 1, 2, and 3, and human metapneumovirus).
Gross, histopathological, and ultrastructural analyses
Gross and histopathological analyses of post-mortem tissues
were performed by a board-certified veterinary pathologist
specializing in nonhuman primate/laboratory animal medicine,
a branch of Primate Services at the CNPRC. At necropsy, tissue
samples from the trachea, lung, and liver were collected and fixed
in 10% formalin. Tissues were routinely processed and embedded
in paraffin. 3-mm sections were stained with hematoxylin and eosin
(HE) and examined by light microscopy. For transmission electron
microscopy, tissue fragments (262 mm) were excised from paraffin
blocks of lung, deparaffinized, and processed as previously
described [48].
Nucleic acid extraction and cDNA library preparation
Total nucleic acid was extracted from body fluid or swab
samples using commercially available kits (Qiagen, Valencia, CA).
200 mL of sample were passed through a 0.22 mm filter (Millipore,
Temecula, CA) to remove bacteria and cellular debris and then
treated with Turbo DNase (Ambion, Culver City, CA) to degrade
host genomic DNA prior to extraction. For tissue samples, lung or
liver tissue was homogenized in a 15 mL Eppendorf tube using a
disposable microtube pestle (Eppendorf, San Diego, CA) and
scalpel, and RNA extraction was then performed using TRIzol LS
(Invitrogen, Carlsbad, CA), followed by isopropanol precipitation
and two washes in 70% ethanol. Extracted nucleic acid was
amplified using a random PCR method to generate cDNA
libraries for Virochip and deep sequencing analyses as previously
described [18,21].
Virochip analysis
The current 8660 k Virochip microarrays used in this study
contain 19,058 70mer probes representing all viral species in
GenBank, and combine probes from all previous Virochip designs
[17,18,21,23]. Four probes derived from 2 different Adenoviridae
genera (SAdV-23, PAdV-A, HAdV-5, and FAdV-D) yielded an
adenovirus signature on the Virochip that was found to be
TMAdV. With the exception of SAdV-23, these highly conserved
probes are part of the core Virochip design and were derived from
all available adenoviral sequences in GenBank as of 2002 [21].
One explanation why more high-intensity probes to simian
adenoviruses were not seen by Virochip analysis is that the
genomes of many simian Ads, including SAdV-3 and SAdV-18
(the two closest phylogenetic relatives to TMAdV in GenBank),
were not sequenced until after 2004 [7,49], and thus their
genomes are not as well-represented on the Virochip microarray.
Virochip analysis was performed as previously described
[21,23]. Briefly, samples were labeled with Cy3 or Cy5 fluorescent
dye, normalized to 10 pmol of incorporated dye, and hybridized
overnight using the Agilent Gene Expression Hybridization kit
(Agilent Technologies, Santa Clara, California). Slides were
scanned at 3 mm resolution using an Agilent DNA Microarray
Scanner. Virochip microarrays were analyzed with Z-score
analysis [18], hierarchical cluster analysis [50], and E-Predict, an
automated computational algorithm for viral species prediction
from microarrays [51]. Only Z-score analysis, a method for
assessing the statistical significance of individual Virochip probes,
yielded a credible viral signature on the microarray.
PCR screening
We initially used consensus primers derived from a highly
conserved region of the hexon gene to confirm the Virochip
finding of an adenovirus by PCR [25]. After recovering the full
genome sequence, we then designed a set of specific PCR primers
for detection of TMAdV, TMAdV-F (59-GTGACGTCA-
TAGTTGTGGTC) and TMAdV-R (59-CTTCGAAGGCAAC-
TACGC). The TMAdV-specific quantitative real-time PCR was
performed on a Stratagene MX3005P real-time PCR system using
a2 5mL master mix consisting of 18 mL of water, 2.5 mL of 10X
Taq buffer, 1 mL of MgCl2 (50 mM), 0.5 mL of deoxynucleoside
triophosphates (dNTPs; 12.5 mM), 0.5 mL of each primer
(10 mM), 0.5 mL SYBR green, 0.5 mLo fTaq polymerase
(Invitrogen, Carlsbad, CA), and 1 mL of extracted nucleic acid.
Conditions for the PCR reaction were 40 cycles of 94uC for 30 s,
55uC for 30 s, and 72uC for 30 s. Amplicons were purified on a
2% agarose gel, cloned into plasmid vectors using TOPO TA
(Invitrogen, Carlsbad, CA), and sent to an outside company (Elim
Biopharmaceuticals, Hayward, CA) for Sanger sequencing in both
directions using vector primers M13F and M13R.
To assess linearity and limits of sensitivity for the TMAdV PCR
assay, 12 serial log dilutions were made of a standard plasmid
constructed by cloning the 157-bp TMAdV amplicon into a
TOPO plasmid vector. Purified plasmid clones at each serial
dilution were quantified using a Nanodrop spectrophotometer and
then spiked into negative serum, stool, or oral swab sample matrix,
each matrix consisting of a pool of 10 sera, 10 stool samples, or 3
oral swabs, respectively. For each sample type, a standard curve
for the TMAdV PCR assay was calculated from 3 PCR replicates
at each dilution of nucleic acid extracted from the spiked matrix
(data not shown). To determine limits of sensitivity for the assay,
probit analysis of results from 6 PCR replicates of 7 serial log
dilutions (from a starting concentration of ,1.2610
5 copies/mL)
was performed using SPSS 16.0 (SPSS Inc., Chicago, IL). By
probit analysis, the 95% limit of detection for TMAdV was 781,
377, or 35 viral genome equivalents/mL for serum, stool, or oral
swab samples, respectively (data not shown).
Whole-genome sequencing
To facilitate whole-genome sequencing of TMAdV, we
prepared amplified cDNA/DNA libraries for deep sequencing
from lung tissue and a lung swab sample from 2 different monkeys
using previously published protocols [23,52]. Briefly, randomly
amplified libraries were cleaved with a Type IIs restriction
endonuclease (GsuI) and truncated adapters were ligated on the
resulting strand ends. Full-length adapters containing strict 6-nt
barcodes were added via an additional 15 cycles of PCR.
Amplified libraries were size-selected on a 2% agarose gel at
approximately 350 bp average length and then sent to an outside
company (Elim Biopharmaceuticals, Hayward, CA) for deep
sequencing on an Illumina Genome Analyzer IIx (Illumina, San
Diego, CA). Paired-end reads were sequenced for 73 cycles in each
direction. Paired-end reads were subsequently filtered to eliminate
low-complexity sequences with a Lempel-Ziv-Welch (LZW)
compression ratio below 0.4 [53], split into individual reads,
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sequences using BLASTN alignments (word size=11, E-val-
ue=1610
25). After low-complexity filtering and barcode/primer
trimming, 11,950,557 sequence reads remained, with each read
consisting of 67 nucleotides, for a total of ,800 megabases of
sequence. Reads were then aligned using BLASTN (word
size=11, E-value=1610
25) and TBLASTX (word size=11, E-
value=1610
25) to the genome sequence of SAdV-18 (Fig. 2B).
Overlapping reads aligning to SAdV-18 were used to assemble
portions of the TMAdV genome with Geneious software (version
3.6.5) [54], employing the SAdV-18 genome as a reference
sequence and requiring a 20-bp minimum overlap and 95%
overlap identity. Aligning reads were also used to design PCR
primers to close remaining gaps in the TMAdV genome.
Amplicons derived from specific TMAdV PCR primers were
gel-purified, cloned, and sequenced as described above. The 59
end corresponding to the inverted terminal repeat (ITR) of
TMAdV was obtained by PCR using a forward degenerate
consensus primer and a reverse TMAdV-specific primer. The 39
end was recovered using a forward primer near the 39 end of the
genome and a reverse primer derived from 59-ITR sequence.
Structural features and phylogenetic analysis
To identify predicted coding regions in the TMAdV genome,
we used the fully annotated genome sequence of SAdV-21 in
GenBank as a reference. First, we aligned the two genomes and
identified all ORFs that were present with Geneious [54]. We then
selected the candidate ORF that best matched the corresponding
ORF in the annotated reference genome. For adenovirus genes
that are spliced (e.g. E1A), the identification of a GT-AG intron
start-stop signal was used to pinpoint the correct ORF. To confirm
the accuracy of the coding sequence, the sequence of each
identified ORF was aligned to a database containing all adenoviral
proteins in GenBank by BLASTX.
To generate whole-genome and individual gene nucleotide
phylogeny trees, all 95 fully sequenced unique adenovirus genomes
were first downloaded from GenBank. Multiple sequence
alignments were then performed on a 48-core Linux system using
ClustalW-MPI [55]. Trees were constructed after bootstrapping to
1000 replicates by the neighbor-joining method (based on Jukes-
Cantor distances) in Geneious [54,56]. Pairwise alignments were
calculated using Shuffle-LAGAN (window size, 400 bp; step size
40 bp; translated anchoring), a glocal alignment algorithm that is
able to calculate optimal alignments by using both local alignments
and global maps of sequence rearrangements (e.g. duplications of
the fiber gene in adenovirus genomes with 2 fibers) [57]. Sliding
window analysis of the Shuffle-LAGAN pairwise alignments was
performed using the online mVISTA platform [58]. More
accurate alignments were obtained with Shuffle-LAGAN than
with either ClustalW-MPI or Geneious (data not shown). Boot-
scanning analysis was performed according to the Kimura 2-
parameter method using 1000 replicates with Simplot (version
3.5.1) [59]. Pairwise amino acid amino acid alignments between
predicted TMAdV proteins and corresponding proteins in other
adenoviruses (Table 2) were performed using Geneious [54].
Virus cultivation
A549 (human lung adenocarcinoma) and BSC-1 (African green
monkey kidney epithelial) cell lines as well as PMK (primary
rhesus monkey kidney) cells are routinely maintained at the Viral
and Rickettsial Disease Laboratory (VRDL) branch of the
California Department of Public Health. Media consisting of
Hank’s medium (for A549 cells) or Dulbecco’s modified Eagle’s
medium (DMEM) (for BSC-1 cells) were supplemented with
16nonessential amino acids (Invitrogen, Carlsbad, CA), 10% fetal
bovine serum, 100 U of penicillin/mL and 100 mg of streptomy-
cin/mL. PMK cells were maintained in tubes containing growth
media and antibodies to SV-40 and SV-5 polyomaviruses
(Viromed, Pasadena, CA). Clinical samples were clarified by
centrifugation for 10 min64000 g and passaged through a 0.2-mm
filter. Cell culture passages were subjected to 3 freeze-thaw cycles
and clarified as above. After achieving 80–90% confluency, cell
culture media were changed to maintenance media with 2% FBS
and were inoculated with 200 mL of clinical sample or 100 mLo f
passaged viral supernatant. Viral replication was monitored over
14 days by visual inspection under light microscopy for cytopathic
effect (CPE). To confirm the generation of infectious virus, viral
supernatants were quantitated by an end-point dilution assay.
Virus neutralization assay (human and monkey sera)
A virus stock of TMAdV (passage 7) was produced on human
A549 cells, aliquoted, and quantitated by end-point dilution. To
perform the virus neutralization assay, 55 mL of viral supernatant
at a concentration of 100 TCID50 and 55 mL of serum (starting at
a 1:8 dilution) were mixed and incubated for 1 hour at 37uC. As a
control for each serum sample, 55 mL of culture media and 55 mL
of serum were mixed and treated in an identical fashion. While
mixtures were incubating, A549 cells grown in T-25 plates were
trypsinized and 4,000 cells in 100 mL of media were added to each
well of a 96-well plate. After incubation, 100 mL of mixture were
inoculated into appropriate wells containing 4,000 cells per well
and the entire plate was placed in a 37uC5 %C O 2 incubator.
Cells in the plate wells were observed for evidence of CPE every
other day for 1 week. For wells that showed inhibition of viral
CPE, the corresponding serum samples were diluted in six 2-fold
steps and then retested. The reciprocal of the highest dilution that
completely inhibited viral CPE was taken as the neutralizing
antibody titer.
Virus neutralization assay (rabbit typing sera)
To assess cross-neutralization of TMAdV by known human
adenoviruses, 7 pools of in-house reference sera at the VRDL
(rabbit hyperimmune sera) and collectively containing antibodies
to human adenovirus serotypes 1 through 35 were available for
testing. For each pool, 55 mL of rabbit sera and 55 mL of viral
supernatant at a concentration of 100 TCID50 were mixed,
incubated for 1 hour at 37uC, and inoculated onto A549 cells in
wells of a 96-well plate as described above. Cells in the plate wells
were observed for evidence of CPE every other day for 1 week.
Microarray and nucleotide sequence accession numbers
All Virochip microarrays used in this study have been submitted
to the NCBI GEO database (study accession number GSE26898;
microarray accession numbers GSM662370-GSM662391; micro-
array design accession number GPL11662). The annotated,
whole-genome sequence of TMAdV has been submitted to
GenBank (accession number HQ913600). Deep sequencing reads
have been submitted to the NCBI Sequence Read Archive
(accession number SRA031285).
Supporting Information
Figure S1 Phylogenetic analysis of the hexon, polymer-
ase, penton base, and fiber genes of TMAdV. A multiple
sequence alignment of selected genes from all 95 unique, fully-
sequenced adenovirus genomes in GenBank and TMAdV is
performed and the results displayed as a radial phylogenetic tree.
The branch corresponding to TMAdV is highlighted in boldface
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(TIF)
Figure S2 Bootscanning recombination analysis of
TMAdV. Bootscanning analysis was initially performed with all
95 unique, fully-sequenced adenovirus genomes in GenBank (data
not shown). After removal of similar viral genomes, bootscan plots
of the whole genome and individual genes from a subset
representing human/simian adenoviruses in species A–G and all
non-primate vertebrate adenoviruses were generated. The window
size is 400 bp with a step size of 40 bp for the whole genome, and
200 bp with a step size of 20 bp for the individual genes. The x-
axis refers to the nucleotide position. For definition of abbrevia-
tions, please refer to Fig. 3.
(TIF)
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